Broadcasting News

Regarding Top and Nana’s Romance… Han Seo-hee Says, “Be Happy”

Top and Nana Confirm They Are Dating

Gim Ga Yeong
2026-10-03 16:39:29
[Edaily Starin Gim Ga Yeong Reporter] Han Seo-hee, a former idol trainee, commented on the romantic relationship between actor T.O.P (formerly of Big Bang) and actress Nana (formerly of After School).
On the 2nd, Han Seo-hee posted “Be happy” on her social media after a netizen commented, “T.O.P. and Nana are dating.”
That same day, following the emergence of dating rumors, T.O.P and Nana acknowledged their relationship, stating, “We met while filming a music video and are currently in a happy relationship.” It is reported that the two met in January while filming T.O.P’s music video and began dating in June.
Previously, Han Seo-hee was indicted in 2017 on charges of smoking marijuana with T.O.P. At the time, T.O.P. was sentenced to 10 months in prison, suspended for two years, while Han Seo-hee was sentenced to three years in prison, suspended for four years.
She was subsequently indicted twice more on drug-related charges and served a one-year-and-six-month prison sentence in July 2022.
Han Seo-hee first gained public recognition as an aspiring entertainer after appearing on MBC’s “The Great Birth Season 3.”

Economy

Corporation

IT·Science

Economy

Kaia Chairman: "It’s the 'Golden Time' for K-Blockchain… It Should Be Operated Using a Won-Pegged Stablecoin"

A proposal has been put forward to establish a Korea-led blockchain infrastructure ahead of the institutionalization of won-pegged stablecoins and security token offerings (STOs). The vision calls for…
2026-11-20 14:50:02

Corporation

curacle co., ltd. Files for U.S. Phase 2b Clinical Trial of CU06, an Oral Treatment for Diabetic Macular Edema

curacle co., ltd.(365270)is moving forward with a U.S. Phase 2b clinical trial to develop an oral treatment for diabetic macular edema (DME). The trial will re-evaluate the treatment’s efficacy in pat…
2026-11-20 13:02:02

IT·Science

Aimed Bio Inc.’s ADC Technology Export Shows 60% Response Rate in Phase 1 Clinical Trial… Moving Forward with U.S. Approval Trials

#Aimed Bio Inc.’s antibody-drug conjugate (ADC) “BHV-1530 (AMB302),” which was licensed to U.S.-based Biohaven, has demonstrated initial anticancer efficacy in a Phase 1 clinical trial. Biohaven plans…
2026-11-20 13:07:02